Skip to main content

Table 3 Numbers and percentage of men ever reporting specified symptoms by treatment group, based on answers to 15,279 questionnaires

From: Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN41194621]

 

Active

Placebo

 

Symptom

n

%

n

%

P

Sickness

192

28.2

197

27.7

0.83

Indigestion

346

50.6

348

49.0

0.54

Full stomach

327

47.8

336

47.3

0.84

New muscular pains

430

62.9

449

63.2

0.91

Rash

182

26.6

208

29.3

0.27

Itching

321

46.9

344

48.4

0.59

Impotence

317

46.4

317

44.6

0.51

Back to article page

Trials

ISSN: 1745-6215